Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cross-Sectional and Longitudinal Assessments of Risk Factors Associated With Hypertension and Moderately Increased Albuminuria Comorbidity in Patients With Type 2 Diabetes: A 9-Year Open Cohort Study Publisher



Alijanvand MH1, 2, 3 ; Aminorroaya A2 ; Kazemi I4 ; Yamini SA5 ; Janghorbani M1, 2 ; Amini M2 ; Mansourian M1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Endocrine and Metabolism Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Student Research Center, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Statistics, College of Science, University of Isfahan, Isfahan, Iran
  5. 5. Department of Engineering and Mathematics, Sheffiled Hallam University, Sheffield, United Kingdom

Source: Diabetes, Metabolic Syndrome and Obesity Published:2019


Abstract

Background: Moderately increased albuminuria (MIA) is strongly associated with hypertension (HTN) in patients with type 2 diabetic mellitus (T2DM). However, the association between risk factors and coexisting HTN and MIA remains unassessed. Objectives: This study aimed to determine both cross-sectional and longitudinal associations of risk factors with HTN and MIA comorbidity in patients with T2DM. Methods: A total of 1,600 patients with T2DM were examined at baseline and longitudinal data were obtained from 1,337 T2DM patients with at least 2 follow-up visits to assess the presence of HTN alone (yes/no), MIA alone (yes/no) and the coexistence of both (yes/no) in a 9-year open cohort study between 2004 and 2013. Bivariate mixed-effects logistic regression with a Bayesian approach was employed to evaluate associations of risk factors with HTN and MIA comorbidity in the longitudinal assessment. Results: After adjustment for age and BMI, patients with uncontrolled plasma glucose, as a combined index of the glucose profile, were more likely to have HTN [odds ratio (OR): 1.73 with 95% Bayesian credible intervals (BCI) 1.29–2.20] and MIA [OR: 1.34 (95% BCI 1.13– 1.62)]. The risks of having HTN and MIA were increased by a one-year raise in diabetes duration [with 0.89 (95% BCI 0.84–0.96) and 0.81 (95% BCI 0.73–0.92) ORs, respectively] and a one-unit increase in non-high-density lipoprotein-cholesterol (Non-HDL-C) [with 1.30 (95% BCI 1.23–1.34) and 1.24 (95% BCI 1.14–1.33) ORs, respectively]. Conclusions: T2DM patients with HTN, MIA, and the coexistence of both had uncontrolled plasma glucose, significantly higher Non-HDL-C, and shorter diabetes duration than the other T2DM patients. Duration of diabetes and uncontrolled plasma glucose index showed the stronger effects on HTN and MIA comorbidity than on each condition separately. © 2019 Hadi Alijanvand et al.
Experts (# of related papers)
Other Related Docs
9. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
10. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
28. Comparison of Different Obesity Indices for Predicting Incident Hypertension, High Blood Pressure and Cardiovascular Prevention (2017)
29. Relationship Between Dietary Patterns and Incidence of Type 2 Diabetes, International Journal of Preventive Medicine (2019)
42. Incidence of Microalbuminuria and Associated Risk Factors in Type 2 Diabetes Mellitus, Iranian Journal of Diabetes and Lipid Disorders (2006)
44. Association of Serum Uric Acid With Proteinuria in Type 2 Diabetic Patients, Journal of Research in Medical Sciences (2013)
46. Cause-Specific Risk Factors of Death in Individuals With Diabetes: A Competing Risks Modeling, International Journal of Endocrinology and Metabolism (2019)